IMR Press / CEOG / Volume 46 / Issue 4 / DOI: 10.12891/ceog4952.2019

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Amenorrhea incidence among symptomatic premenopausal women with uterine fibroids after uterine artery embolization (UAE). Our experience
Show Less
1 Departmnet of Obststrics and Gynecology,Democritus University of Thrace, Alexandroupolis, Greece
2 Department of Radiology and Medical Imaging, Democritus University of Thrace, Alexandroupolis, Greece
*Correspondence: ptsikour@med.duth.gr (P. TSIKOURAS)
Clin. Exp. Obstet. Gynecol. 2019, 46(4), 618–622; https://doi.org/10.12891/ceog4952.2019
Published: 10 August 2019
Abstract

Objective: To study the impact of uterine artery embolism (UAE) for fibroids on menstrual cycle and cases of amenorrhoea in premenopausal women. Materials and Methods: One hundred forty-five premenopausal women, aged between 38-50 years, who underwent UAE were recruited in this study. Hormonal status was evaluated by means of AMH and FSH pre-procedural, three months, six, and 12 months after UAE. Menstruation abnormalities and life quality post-procedure were noted and evaluated based on a questionnaire. Results: AMH as well as FSH values 12 months post-procedure were the same compared to the pre-procedure levels. The authors found no case of permanent amenorrhea. Conclusion: Although the study results may be able to confirm the preservation of ovarian reserve and normal menstruation after UAE in premenopausal women, it should be considered as a possible menstruation treatment option of symptomatic fibroids.

Keywords
Uterine artery embolization
Uterine fibroids
Share
Back to top